Moreover, hyperphosphatemia seems to be related to the increase in the fibroblast growth factor 23 (FGF23) levels and to the decrease in its co-receptor expression, called Klotho, which are ED-inducing factors. The gene discussed is FGF23; the disease is hyperphosphatemia.